Virome-capture-sequencing (VirCapSeq) for viral infection diagnosisCU18221VirCapSeq-VERT: a high-throughput, cost-effective viral capture and sequencing platform enabling broad, sensitive vertebrate virus detection and discovery.TagsChain reactionDNA sequencingMassive parallel sequencingInventorsW. Ian Lipkin M.D.Cheng GuoNischay MishraManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2025-09-04
An improved virome-capture-sequencing method for viral diagnosis and virus discoveryCU24096Improved virome capture sequencing boosts vertebrate virus detection with fewer probes, lower costs, and broader viral coverage.TagsAcidCerebrospinal fluidChemical libraryInventorsW. Ian Lipkin M.D.Thomas BrieseManagerKristin NeumanDepartmentsEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2026-03-06
Diagnostic peptides for Lyme disease serodiagnosisCU25107Rapid, affordable Lyme diagnostic using two specific peptides; enables early, at-home, point-of-care serodiagnosis with higher accuracy.TagsAntibioticAntibodyBorrelia burgdorferiInventorsW. Ian Lipkin M.D.Rafal TokarzManagerKristin NeumanDepartmentsEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2025-04-04
A peptide microarray for serodiagnosis of exposure to high-threat hemorrhagic fever virusesCU23088Peptide microarray identifies immunoreactive epitopes for high-specificity serodiagnosis of hemorrhagic fevers, distinguishing infection from vaccination.TagsAntibodyBlood plasmaBlood transfusionInventorsW. Ian Lipkin M.D.Lisa HensleyNischay MishraManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2024-01-10CollectionsPlatform/Research Tool
Diagnosis of viral disease in tilapia populationsCU15044Identifies TiLV-specific nucleic acid and protein markers for rapid, high-throughput tilapia viral diagnostics and monitoring.TagsDNA sequencingFish farmingHigh-throughput screeningInventorsW. Ian Lipkin M.D.Nischay MishraSandra Abel NielsenManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2015-11-06
Genetic sequence database for identifying bacteria, pathogenicity, and antibiotic resistanceCU23199Curated million-sequence database enabling rapid bacterial ID, virulence and antibiotic-resistance detection for diagnostics.TagsAntimicrobial resistanceBiological databaseDrug developmentInventorsW. Ian Lipkin M.D.Amit RanjanCheng GuoManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2025-08-29
One step assay for rapid and selective diagnosis of arbovirusesCU16221Multiplex one-step qPCR quickly differentiates Zika, Dengue, Chikungunya, and West Nile from serum or urine samples.TagsArbovirusAssayChikungunyaInventorsW. Ian Lipkin M.D.Nischay MishraRafal TokarzManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2017-08-18
Method for identifying vertebrate viruses using multiplexed, high-throughput genome sequencingCU16058Virome-Capture-Sequencing (VirCapSeq-VERT) enables high-throughput, cost-effective vertebrate virus detection and discovery.TagsChemical libraryGlobal healthUlcerative colitisInventorsW. Ian Lipkin M.D.Amit KapoorOmar JabadoManagerKristin NeumanDepartmentsBiological SciencesEpidemiologyMailman School Of Public Health (MSPH)DivisionsFaculty of the Arts & SciencesMailman School Of Public Health (MSPH)Release Date2025-09-04
High-throughput assay for detection of Zika exposureCU17122High-throughput Zika serology using epitope signatures enables rapid, differential exposure detection, distinguishing past from acute infections.TagsAssayChikungunyaDifferential diagnosisInventorsW. Ian Lipkin M.D.Adrian CaciulaNischay MishraManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2018-02-15
Method of biomarker testing for autism spectrum disorder for early interventionCU23349Biomarker-based newborn metabolomic profiling enables early ASD risk identification and intervention, enhancing timely, personalized treatment.TagsApplied behavior analysisAutism spectrumBlood plasmaInventorsW. Ian Lipkin M.D.Camilla StoltenbergOliver FiehnManagerKristin NeumanDepartmentsBiostatisticsEpidemiologyMolecular and Cellular BiologyDivisionsMailman School Of Public Health (MSPH)Technology Transfer ServicesRelease Date2024-02-15CollectionsCNS/NeurologyMedical Device
Rapid Molecular Differential Detection of SARS-CoV-2CU20260Rapid, multi-virus PCR assay enables differential, rapid detection of SARS-CoV-2, influenza A/B, improving diagnostic accuracy.TagsAssayBlood plasmaEpidemiologyInventorsW. Ian Lipkin M.D.Nischay MishraSimon H. WilliamsManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2022-08-20
Serochip for the diagnosis of tick-borne diseasesCU19325A programmable peptide microarray enables rapid, high-throughput, single-step serologic diagnosis of multiple tick-borne diseases.TagsAntibodyAssayEpidemiologyInventorsW. Ian Lipkin M.D.Adrian CaciulaNischay MishraManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2025-09-04
Multiplexed serological platform for detection of SARS-CoV-2 exposureCU20309High-throughput microarray identifies SARS-CoV-2–specific epitopes, distinguishing them from other coronaviruses for precise serodiagnosis.TagsAntibodyCoronavirusEpitopeInventorsW. Ian Lipkin M.D.Cheng GuoJiahai LuManagerKristin NeumanDepartmentsCenter for Infection and ImmunityEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2020-04-02CollectionsPlatform/Research Tool
Nanobodies for diagnosis, treatment and prevention of infection and disease caused by SARS-CoV-2 and variantsCU21304Broad-spectrum SARS-CoV-2 nanobodies enable diagnosis, treatment, and prevention across variants with easier delivery and stability.TagsAngiotensinAssayEnzymeInventorsW. Ian Lipkin M.D.Thomas BrieseManagerKristin NeumanDepartmentsEpidemiologyDivisionsMailman School Of Public Health (MSPH)Release Date2023-02-17CollectionsPlatform/Research Tool
